Denosumab 60 mg biologics rebate agreements

Summary

The tender concerns rebate agreements for biologics containing denosumab 60 mg under an open-house procedure. Techniker Krankenkasse intends to conclude contracts with all suitable pharmaceutical companies on uniform terms; there are no individual negotiations and no exclusivity is granted. The contract term is a maximum of 17 months starting on 01/07/2026 and ending no later than 30/11/2027. The exact participation and contract conditions must be checked in the participation and contract documents.